Edition:
India

Strides Pharma Science Ltd (SRID.NS)

SRID.NS on National Stock Exchange of India

376.30INR
23 Aug 2019
Change (% chg)

Rs-0.85 (-0.23%)
Prev Close
Rs377.15
Open
Rs377.15
Day's High
Rs380.90
Day's Low
Rs366.85
Volume
831,609
Avg. Vol
1,358,831
52-wk High
Rs551.40
52-wk Low
Rs337.55

About

Strides Pharma Science Ltd, formerly Strides Shasun Limited, is a vertically integrated global pharmaceutical company. The Company is engaged in the development and manufacturing of active pharmaceutical ingredients (APIs) and formulations, as well as biotech. Its business segments include Pharmaceutical and Biotech businesses.... (more)

Overall

Beta: 0.59
Market Cap(Mil.): Rs74,972.77
Shares Outstanding(Mil.): 89.49
Dividend: 4.50
Yield (%): 0.54

Financials

  SRID.NS Industry Sector
P/E (TTM): 21.94 29.89 32.67
EPS (TTM): 38.19 -- --
ROI: -- 14.89 14.48
ROE: -- 16.01 15.78

Morning News Call - India, July 18

To access a PDF version of this newsletter, please click here http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_07182019.pdf If you would like to receive this newsletter via email, please register at: http://solutions.refinitiv.com/MNCIndiaSubscriptionpage FACTORS TO WATCH LIVECHAT - BONDS UPDATE Reuters European Government Bonds Correspondent Abhinav Ramnarayan delves into sovereign bond markets at 5:00 pm IST. To join the conversation, click on t

18 Jul 2019

U.S. FDA says Indian drugmaker Strides Pharma Science was shredding, dumping key documents

BENGALURU A U.S. Food and Drug Administration (FDA) investigator discovered that India's Strides Pharma Science Ltd, which exports to the U.S. market, was shredding drug production, quality and laboratory documents and dumping others in a scrap yard.

17 Jul 2019

UPDATE 2-U.S. FDA says Indian drugmaker was shredding, dumping key documents

BENGALURU, July 17 A U.S. Food and Drug Administration (FDA) investigator discovered that India's Strides Pharma Science Ltd, which exports to the U.S. market, was shredding drug production, quality and laboratory documents and dumping others in a scrap yard.

17 Jul 2019

India's Strides tried to shred quality-control documents: FDA

BENGALURU The U.S. Food and Drug Administration (FDA) has raised doubts about Strides Pharma Sciences Ltd's quality-control practices after finding adulteration and evidence of "uncontrolled shredding of documents" at one of its plants.

17 Jul 2019

US FDA finds "significant violations" at India's Strides plant

July 17 The U.S. Food and Drug Administration (FDA) said it found adulteration and "significant violations" of current good manufacturing practice (CGMP) regulations at Strides Pharma Sciences Ltd's plant in Puducherry in south India.

17 Jul 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates